CJC-1295 No DAC + Ipamorelin — 10MG Research Peptide Blend

CJC-1295 No DAC + Ipamorelin is a dual-peptide formulation designed for advanced laboratory research into growth hormone–releasing pathways. This combination pairs CJC-1295 (No DAC) — a short-acting GHRH analogue — with Ipamorelin, a selective GHRP (Growth Hormone Releasing Peptide). Together, they are studied for their complementary activity in stimulating GH secretion and cellular signalling in controlled experimental conditions. Lazarus Labs provides this synergistic formulation in a pharmaceutical-grade lyophilised form, ensuring exceptional purity, solubility, and reproducibility for precision research applications.

Why Researchers Choose Lazarus Labs

Every vial is produced in a GMP-compliant, ISO-certified facility and validated by third-party HPLC and LC-MS testing to confirm ≥ 99 % purity, structure, and composition. Lazarus Labs formulations are trusted for consistency, molecular accuracy, and laboratory reliability across a wide range of peptide studies.

Product Highlights

• Total Concentration: 10 mg per vial
• Composition: CJC-1295 No DAC (5 mg) + Ipamorelin (5 mg)
• Purity: ≥ 99 % (independently verified)
• Solubility: Fully soluble in water (H₂O)
• Manufacturing: GMP + ISO 9001:2008 compliant
• Use: Designed for growth hormone, receptor-binding, and peptide signalling research

Storage

Keep sealed and stored dry at 2–8 °C. Once reconstituted, refrigerate and use within 6 weeks.